Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

AIDS-Related Malignancies.

Wool1

  • 1Los Angeles, California, USA. mwool@ucla.edu

The Oncologist
|July 1, 1999
PubMed
Summary
This summary is machine-generated.

Highly active antiretroviral therapy has not reduced human immunodeficiency virus (HIV)-associated cancers. This review covers HIV-associated malignancies, their presentation, and treatment, including myelosuppression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dynamics of Polymer Interdiffusion: The Ripple Experiment.

Macromolecules·1998
Same journal

The Impact of Relative Dose Intensity on pCR in Neoadjuvant Chemotherapy of Muscle-Invasive Urothelial Cancer: a Multicentre Retrospective Study.

The oncologist·2026
Same journal

Prevalence, treatment and survival of Malignant Peripheral Nerve Sheath Tumor in the Danish neurofibromatosis type 1 population.

The oncologist·2026
Same journal

Molecular Tumor Board-Guided Osimertinib Therapy in EGFR L858R/Q701L-Mutant Lung Adenocarcinoma Supported by Functional Validation.

The oncologist·2026
Same journal

Phase 2 Dose Expansion Trial of OBI-3424, a DNA-Alkylating Prodrug, in Patients with Advanced Solid Tumors Expressing AKR1C3.

The oncologist·2026
Same journal

Divergent Biology and Outcomes of Somatic Transformations in Germ Cell Tumors.

The oncologist·2026
Same journal

Modernizing Disease Assessment in Prostate Cancer Trials: The Prostate Cancer Working Group 4 Framework.

The oncologist·2026
See all related articles

Area of Science:

  • Oncology
  • Infectious Diseases
  • Immunology

Background:

  • The advent of highly active antiretroviral therapy (HAART) has not decreased the incidence of human immunodeficiency virus (HIV)-associated malignancies.
  • The Centers for Disease Control (CDC) defines Kaposi's sarcoma, non-Hodgkin's lymphoma (including primary central nervous system lymphoma), and cervical carcinoma as defining acquired immune deficiency syndrome (AIDS).
  • Other cancers like Hodgkin's disease, anal carcinoma, lung cancer, and non-melanomatous skin cancers are also frequently observed in HIV-infected individuals.

Purpose of the Study:

  • To review the clinical presentation and current treatment strategies for HIV-associated malignancies.
  • To discuss selected other tumors commonly found in HIV-infected patients.
  • To address the challenges of managing malignancy in patients with concurrent compromised marrow function.

Related Experiment Videos

Main Methods:

  • Literature review of clinical presentations and treatment modalities for HIV-associated cancers.
  • Analysis of epidemiological data on cancer incidence in HIV-infected populations.
  • Discussion of myelosuppression as a complicating factor in HIV-infected patients with malignancy.

Main Results:

  • Despite HAART, HIV-associated malignancies remain a significant clinical challenge.
  • Specific cancers (Kaposi's sarcoma, NHL, cervical cancer) are key indicators of AIDS.
  • HIV-associated myelosuppression is prevalent in patients with suboptimal or resistant antiviral treatment.

Conclusions:

  • Effective management of HIV-associated malignancies requires a comprehensive approach considering both cancer treatment and HIV status.
  • Oncologists face unique challenges when treating malignancies in immunocompromised HIV-infected patients.
  • Further research is needed to improve treatment outcomes and address myelosuppression in this population.